Fletcherspaght.com Website Review

Strategy consulting to innovate and accelerate organic and inorganic growth. FSI’s approach draws on the an*lytical methods of strategy consulting, ability to develop primary information, expertise in specific technologies, knowledge of specific vertical markets and broad experience in growth development, business planning and FSI’s services reflect management’s needs relative to increasing revenue growth, long-term potential and enterprise value. Our mandate: FSI partners with clients across the globe to maximize revenue growth and business potential. FSI’s strategy consulting practice is focused on as*isting clients to enhance enterprise value through increasing revenue growth and FSI’s clients pursue opportunities globally and at each stage of development. Guy is a senior member of FSI’s Healthcare Practice and has over 30 years of experience in health care, life sciences, and biotechnology. Previously, Dr. Fish was Vice President of Business Development and International at Collagenesis, a tissue-engineering firm. He has also worked as a securities an*lyst in the medical devices sector for Sanford Bernstein, as a healthcare consultant at The Boston Consulting Dr. Fish is a Trustee Advisor of Beth Israel Deaconess Medical Center in Boston, where he previously chaired the Patient Care Committee, and holds membership on the Patient Care As*essment and Quality Committee, and Medical Education Committee. He has served as Chairman of the Licensing Board for Dubai Health Care, as well as the Licensing Committee for the Board of Registration in Medicine for the Commonwealth of Mas*achusetts. Dr. Fish is currently a member of the Board of Directors of Altarum Institute, Phase Biosciences, and is a Dr. Fish holds an MBA from the Yale School of Management, an MD from the Yale School of Medicine, and an AB in biochemistry from Harvard